Bg. Issa et al., GLUTAMATE PATHWAYS MEDIATE SOMATOSTATIN RESPONSES TO GLUCOSE IN NORMAL AND DIABETIC RAT HYPOTHALAMUS, Journal of neuroendocrinology, 10(5), 1998, pp. 377-381
We investigated the role of hypothalamic glutamate receptors in mediat
ing the stimulatory effect of low glucose (< 5 mM) on somatostatin rel
ease. We also studied whether alteration in glutamate release might co
ntribute to the reduced hypothalamic somatostatin response to low gluc
ose observed in diabetic (Goto-Kakizaki) rat hypothalami. Hypothalamic
somatostatin release in response to incubation with 1 mM D-glucose wa
s inhibited by the ionotropic glutamate receptor antagonists MK801, D-
AP5 and DNQX but not by the metabotropic antagonists L-AP3 or MCPG., T
he release of somatostatin was increased by the ionotropic agonists NM
DA, AMPA and kainate but not by metabotropic agonists t-ACPD or L-AP4.
Basal and peak glutamate release in response to incubation with 1 mM
glucose, were significantly lower from GK hypothalami There were no si
gnificant differences in the basal or stimulated release of serine and
GABA. These data indicate that ionotropic NMDA/AMPA/kainate receptors
and not metabotropic receptors mediate the effects of glucose on rat
hypothalamic somatostatin release. Reduced hypothalamic somatostatin r
elease in response to low glucose in diabetic (Goto-Kakizaki) rats may
well be secondary, at least in part, to reduced glutamate release.